Sydnexis (Series B)

Funding Details
Awarder
Inbox
Date Award
August 10, 2021
Vertical
Pharmaceuticals
Funding URL
View Funding Page
Funding Amount:
$45,000,000

Company Info
Company Description
Sydnexis is engaged in the development of a proprietary treatment for pediatric progressive myopia.
Market
Clinical Stage Drug Development
Location
Del Mar, California, USA
Coinvestors
Blue Stem Capital, Longitude Capital, Medicxi, RA Capital Management, SC Master Fund, Visionary Ventures Fund

Links